Renaissance Technologies - ONCOCYTE CORP ownership

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 52 filers reported holding ONCOCYTE CORP in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q2 2023$32
+52.4%
138,100
+131.7%
0.00%
Q1 2023$21
+133.3%
59,600
+111.3%
0.00%
Q4 2022$9
-100.0%
28,200
-82.1%
0.00%
Q1 2022$235,000
-35.4%
157,450
-6.2%
0.00%
Q4 2021$364,000
+79.3%
167,900
+195.1%
0.00%
Q3 2021$203,000
-53.2%
56,900
-24.7%
0.00%
-100.0%
Q2 2021$434,000
-24.1%
75,600
-31.5%
0.00%0.0%
Q1 2021$572,000
+300.0%
110,300
+47.7%
0.00%
Q2 2020$143,000
-73.4%
74,700
-45.2%
0.00%
Q1 2019$538,000136,2000.00%
Other shareholders
ONCOCYTE CORP shareholders Q1 2019
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 17,349,945$61,766,0003.15%
Defender Capital, LLC. 1,960,820$6,935,0002.26%
Millrace Asset Group, Inc. 613,885$2,185,0001.36%
PURA VIDA INVESTMENTS, LLC 12,223,953$43,517,0001.32%
Penbrook Management LLC 577,200$2,055,0001.28%
ACT CAPITAL MANAGEMENT, LLC 330,000$1,175,0000.61%
AWM Investment Company, Inc. 717,000$2,553,0000.25%
Colonial River Wealth Management, LLC 66,200$218,0000.15%
CALIBER WEALTH MANAGEMENT, LLC 66,200$218,0000.15%
Fort Sheridan Advisors LLC 110,000$392,0000.13%
View complete list of ONCOCYTE CORP shareholders